Skip to main content

JANE STREET GROUP, LLC

Position in CGON — CG Oncology, Inc.

CIK 1595888 NEW YORK, NY

Position in CGON

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$209,604
+$209,604 QoQ
Shares Held
3,097
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CGON Over Time

Shares Held

Position Value (USD)

Derivatives in CGON

reported options exposure · as of Mar 31, 2026
CallValue
$2,098,080
CallShares
31,000
PutValue
$3,864,528
PutShares
57,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,247,243,084 across 314 Biotechnology names. CGON ranks #215 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CGON

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,864,528 57,100
2026-03-31 $209,604 3,097
2026-03-31 $2,098,080 31,000
2025-12-31 $2,756,928 66,400
2025-12-31 $1,689,864 40,700
2025-09-30 $418,912 10,400
2025-09-30 $551,836 13,700
2024-12-31 $576,468 20,100
2024-12-31 $1,759,862 61,362
2024-09-30 $7,393,231 195,951
2024-06-30 $1,816,884 57,551
2024-03-31 $3,351,896 76,353